Biogen beats estimates on cost cuts and new drugs like Leqembi, but profit outlook falls short
Biogen expects Leqembi and new rare disease and depression treatments to help offset revenue lost from multiple sclerosis ...
Here's how Trump's tariffs on China could impact drug pricing and other healthcare costs
While Trump's tariffs could have a broad impact on healthcare prices, it is likely they will not have the devastating result ...
Drug lord's son-in-law pleads guilty in border price-fixing scheme
The son-in-law of a Mexican drug lord entered a guilty plea over an 11-year price-fixing scheme that used deadly force along ...
Trump is unlikely to end Medicare drug price talks — here's what that means for patients and pharma
Trump could either weaken the negotiations in a way that benefits the pharmaceutical industry, or try to achieve even deeper ...
Medicare Drug Coverage Is Often Inadequate—Here’s Why
She learned that she would have to try, and "fail," on two other drugs before Medicare would cover the new one.
Commonwealth Fund4d
Drug Costs and Their Impact on Care: Insights from Medicare Patients and Providers
Providers are sympathetic to Medicare enrollees’ concerns but don’t agree on their role in helping patients find less costly ...
How Medicare Says It Arrives At ‘Fair’ Prescription Drug Prices
We now have a glimpse behind the curtain of how Medicare arrives at so-called maximum fair prices of prescription drugs it ...
Hosted on MSN21m
Senator Gillibrand announces legislation to reduce prescription drug costs
On Wednesday, Senator Kristen Gillibrand announced legislation to help reduce prescription drug costs. According to the ...
WNYT NewsChannel 131d
Gillibrand seeks to cap out-of-pocket drug costs
U.S. Sen. Kirsten Gillibrand is proposing legislation to reduce the cost of prescription drugs. The Capping Prescription ...
EURweb on MSN1d
Two New California Bills Are Aiming to Lower Your Prescription Drug Costs
California Sen. Scott Wiener’s SB 40 & SB 41 aim to reduce prescription costs with insulin affordability & PBM reform ...
Attack drug costs
Recently, a letter to the editor I wrote was published in the Arkansas Democrat-Gazette on the subject of skyrocketing health-care costs, inclusive of rising pharmaceutical drug prices. I referenced ...
Pharmacy benefit management unicorn Capital Rx hits $3.5 billion in revenue with a different approach to drug pricing as Congress targets middlemen
Healthcare startup Capital Rx seeing revenue surge as Congress seeks to regulate the PBM giants that profit from high drug ...